Amedisys Price to Book Ratio 2010-2024 | AMED

Historical price to book ratio values for Amedisys (AMED) over the last 10 years. The current price to book ratio for Amedisys as of December 25, 2024 is 2.32.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Amedisys Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-12-26 85.95 2.34
2024-09-30 96.51 $36.65 2.63
2024-06-30 91.80 $36.01 2.55
2024-03-31 92.16 $34.97 2.64
2023-12-31 95.06 $34.28 2.77
2023-09-30 93.40 $33.51 2.79
2023-06-30 91.44 $32.53 2.81
2023-03-31 73.55 $34.83 2.11
2022-12-31 83.54 $34.04 2.45
2022-09-30 96.79 $32.93 2.94
2022-06-30 105.12 $32.04 3.28
2022-03-31 172.29 $31.34 5.50
2021-12-31 161.88 $30.03 5.39
2021-09-30 149.10 $29.11 5.12
2021-06-30 244.93 $26.89 9.11
2021-03-31 264.79 $24.24 10.92
2020-12-31 293.33 $24.71 11.87
2020-09-30 236.43 $23.10 10.24
2020-06-30 198.54 $22.26 8.92
2020-03-31 183.54 $21.01 8.74
2019-12-31 166.92 $19.87 8.40
2019-09-30 131.01 $18.71 7.00
2019-06-30 121.41 $17.52 6.93
2019-03-31 123.26 $16.27 7.58
2018-12-31 117.11 $15.09 7.76
2018-09-30 124.96 $13.98 8.94
2018-03-31 60.34 $16.14 3.74
2017-12-31 52.71 $15.20 3.47
2017-09-30 55.96 $15.13 3.70
2017-06-30 62.81 $14.57 4.31
2017-03-31 51.09 $14.33 3.56
2016-12-31 42.63 $13.73 3.11
2018-06-30 85.46 $12.86 6.64
2016-09-30 47.44 $13.30 3.57
2016-06-30 50.48 $12.77 3.95
2016-03-31 48.34 $12.32 3.92
2015-12-31 39.32 $12.21 3.22
2015-09-30 37.97 $11.70 3.25
2015-06-30 39.73 $11.29 3.52
2015-03-31 26.78 $10.92 2.45
2014-12-31 29.35 $11.84 2.48
2014-09-30 20.17 $11.49 1.76
2014-06-30 16.74 $11.18 1.50
2014-03-31 14.89 $11.13 1.34
2013-12-31 14.63 $11.45 1.28
2013-09-30 17.21 $11.66 1.48
2013-06-30 11.60 $14.48 0.80
2013-03-31 11.12 $14.71 0.76
2012-12-31 11.31 $14.61 0.77
2012-09-30 13.82 $18.08 0.76
2012-06-30 12.45 $17.28 0.72
2012-03-31 14.46 $17.25 0.84
2011-12-31 10.91 $17.55 0.62
2011-09-30 14.82 $17.05 0.87
2011-06-30 26.63 $31.11 0.86
2010-12-31 33.50 $30.09 1.11
2010-09-30 23.80 $29.95 0.79
2010-06-30 43.98 $28.78 1.53
2010-03-31 55.22 $27.59 2.00
2009-12-31 48.60 $26.12 1.86
2011-03-31 35.00 $30.71 1.14
2009-09-30 43.63 $24.57 1.78
2009-06-30 33.02 $23.19 1.42
2009-03-31 27.49 $21.91 1.25
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.789B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.525B 11.81
Quest Diagnostics (DGX) United States $17.124B 17.35
DaVita (DVA) United States $12.715B 16.44
Encompass Health (EHC) United States $9.488B 22.37
Chemed (CHE) United States $7.824B 24.05
Elanco Animal Health (ELAN) United States $5.873B 13.98
RadNet (RDNT) United States $5.431B 120.26
Option Care Health (OPCH) United States $3.882B 18.40
LifeStance Health (LFST) United States $2.789B 0.00
Addus HomeCare (ADUS) United States $2.337B 27.42
Astrana Health (ASTH) United States $1.883B 25.75
U.S Physical Therapy (USPH) United States $1.362B 35.82
Pennant (PNTG) United States $0.925B 37.42
Aveanna Healthcare Holdings (AVAH) United States $0.854B 0.00
Atai Life Sciences (ATAI) Germany $0.206B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.006B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00